REDCap administrators from around the world recently attended the 14th edition of REDCapCon in Boston, hosted this year by Harvard Catalyst, Harvard University’s center for clinical and translational science.

Vanderbilt researchers will lead and comprise the greater part of an artificial intelligence research ethics core for a National Institutes of Health (NIH) program called Bridge to Artificial Intelligence, or Bridge2AI.

Vanderbilt policy experts discuss how the recent U.S. Supreme Court decision overturning Roe v. Wade and newly enacted state laws limiting or banning abortion can be expected to bring new scrutiny to the privacy vulnerabilities of electronic health records.

Using a high-throughput informatics technique and electronic health records, Vanderbilt researchers found that COVID-19 survivors had an increased risk for more than 40 new diagnoses.

The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.

Vanderbilt is partnering with Yale School of Medicine, Morehouse School of Medicine and the Research Centers in Minority Institutions Coordinating Center at the Morehouse School of Medicine in an initiative aimed at boosting participation in clinical trials.

Vanderbilt University Medical Center has received a five-year, $4.5 million grant from the National Human Genome Research Institute to assess clinical outcomes and economic value of screening large, diverse health care populations for disease risk using polygenic risk scores.